A 10-year-old girl with a history of abdominal migraines has just at the ED, complaining of new-onset, nonbilious, nonbloody vomiting; abdominal pain.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.